None listed
Conditions
Brief summary
This study will evaluate the feasibility and acceptability of implementing a nurse-led screening assessment for older adults with cancer Who is it for? You may be eligible to join this study if you are aged 65 years or older, have been diagnosed with cancer and attend one of the cancer clinics who are implementing the screening assessments into routine practice. Study details All cancer clinics will start in the control arm and transition to intervention arm, but the order in which they transition will be allocated randomly (i.e. by chance). During the control arm period older people with cancer attending the clinic will have clinical assessments as decided by the multidisciplinary cancer treatment team. The intervention arm will receive a screening assessment administered by the cancer nurse to assess for mobility, self-rated health, appetite or weight changes and psychological concerns, Further comprehensive geriatric assessment may also be administered if needed to assess physical function, weight, nutritional status, cognition, other medical conditions, medication, and psychosocial wellbeing.
Interventions
The assessment is conducted with a trained nurse and the different components can be assessed sequentially over a period of time up to 4 weeks after index clinic visit. The assessment comprises of:
1: Routine introduction of nurse - administered screening tools (TRIAGE) which are completed in 10 minutes or less in the clinic or over the phone
(G8 geriatric screening tool, Vulnerable Elders Survey -13, CRASH (Chemotherapy Risk
Assessment Scale for High-Age patients), and CARG chemotherapy toxicit
The assessment is conducted with a trained nurse and the different components can be assessed sequentially over a period of time up to 4 weeks after index clinic visit. The assessment comprises of: 1: Routine introduction of nurse - administered screening tools (TRIAGE) which are completed in 10 minutes or less in the clinic or over the phone (G8 geriatric screening tool, Vulnerable Elders Survey -13, CRASH (Chemotherapy Risk Assessment Scale for High-Age patients), and CARG chemotherapy toxicity calculator); 2: Comprehensive Geriatric Assessment (CGA) when further assessment is indicated by screening using interRAI system) which is conducted in 60 minutes or less in the clinic; and; 3: Communication of Screening and/or CGA to treating medical and/or radiation Oncologist (assessment entered into medical record and email or verbal communication)
Sponsors
Palliative Care Clinical Studies Collaborative
Study design
Allocation
Randomised controlled trial
Intervention model
Other
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Healthy volunteers
No
Inclusion criteria
-Cluster (oncology clinic in integrated cancer centre) level: Inclusion criteria: • Ambulatory Clinics in integrated cancer centres who provide assessment for adult cancer patients. • Written informed consent of the oncologist providing clinical care in the index clinic -New clinic patients contributing de-identified data Inclusion criteria: • Aged 65 years or older •Diagnosis of cancer • First clinic assessment at index clinic with new cancer diagnosis OR first clinical assessment for new occurrence of recurrent or progressive disease -Individual participants of sub-studies Two groups of participants will be involved in the sub-studies: i) patients, ii) treating oncologists and registrars, as per the inclusion and exclusion criteria listed below. -Patient participants - qualitative sub-study Inclusion criteria: •Aged 65 years or older • Diagnosis of cancer • Attended the index oncology clinic • Received the screening and/or CGA assessment • English speaking or availability of a health care interpreter • Able to give fully informed written consent • Able to participate in a brief semi-structured interview -Oncologist or Oncology Registrar – qualitative sub-study Inclusion criteria: • Medical or Radiation Oncologist(s) or Registrar who is involved in the clinical care and/or clinical decision making for patients seen in index oncology clinic • Written informed consent
Exclusion criteria
nil
Outcome results
None listed